CRC Oncology

CRC Oncology is an active contract research organization (CRO) and regulatory affairs consultancy focused on supporting pharmaceutical and biotech companies in oncology. The firm specializes in comprehensive regulatory strategies, independent GxP auditing, FDA inspection preparation, clinical/nonclinical design consulting, CMC planning, expedited approval pathways guidance (IND to NDA/BLA), and strategic labeling planning. They do not have their own therapeutic pipeline but play a key role in enabling the development of innovative cancer therapies by ensuring compliance and optimizing processes for clients navigating the US FDA landscape.